- Integra LifeSciences Holdings ( NASDAQ: IART ) is scheduled to announce Q4 earnings results on Wednesday, February 22nd, before market open.
- The consensus EPS Estimate is $0.90 (+7.1% Y/Y) and the consensus Revenue Estimate is $398.57M (-1.7% Y/Y).
- Over the last 2 years, IART has beaten EPS estimates 100% of the time and has beaten revenue estimates 100% of the time.
- Over the last 3 months, EPS estimates have seen 4 upward revisions and 1 downward. Revenue estimates have seen 4 upward revisions and 2 downward.
For further details see:
Integra LifeSciences Holdings Q4 2022 Earnings Preview